From: Assessment of the hepatocyte protective effects of gypenoside and its phosphorylated derivative against DHAV-1 infection on duck embryonic hepatocytes
Group
Drug concentration (μg/mL)
Average brown florescence rate (%)
CC
0
11.70 ± 0.15d
VC
35.89 ± 1.07a
GPC
100
12.81 ± 0.25d
pGPC
25
12.42 ± 0.10d
GP
18.47 ± 0.21b
pGP
14.99 ± 0.43c